Search - tctmd.com

Displaying 941 - 960 of 1282

Sort: Relevancy | Date

News Daily News

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Leah Lawrence

April 29, 2015

News Daily News

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

L.A. McKeown

April 28, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

News Daily News

元分析解释了不同DAPT时间长短的影响

Caitlin E. Cox

April 03, 2015

News Daily News

Un Meta Análisis Arrojan Luz sobre el Impacto de la Duración del Tratamiento Antiplaquetario Doble

Caitlin E. Cox

April 03, 2015

News Daily News

Meta-analyses Shed Light on the Impact of DAPT Duration

Caitlin E. Cox

April 03, 2015

News Daily News

BRIGHT 发布：直接 PCI 患者长时间输注比伐卢定可减少出血并控制早期支架血栓形成

April 03, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

April 03, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

News Daily News

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Yael L. Maxwell

March 24, 2015

Presentation

Mortality in Pts Treated With Extended Duration Dual Antiplatelet Therapy (DAPT) After DES

Presenter: T. Palmerini

March 18, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Conference News ACC 2015

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Todd Neale

March 14, 2015

News Daily News

Poor Responders to Statins at Risk for CAD Progression

March 11, 2015

Presentation

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Presenter: Martine Gilard

March 10, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Un Estudio del Mundo Real Avala el Uso de Fondaparinux sobre Heparina en el Manejo de los cuadros de NSTEMI

Todd Neale

February 22, 2015

Presentation CADECI 2015

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Presenter: DR. JOSE LUIS LEIVA PONS

February 20, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

Advertisement

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

元分析解释了不同DAPT时间长短的影响

Un Meta Análisis Arrojan Luz sobre el Impacto de la Duración del Tratamiento Antiplaquetario Doble

Meta-analyses Shed Light on the Impact of DAPT Duration

BRIGHT 发布：直接 PCI 患者长时间输注比伐卢定可减少出血并控制早期支架血栓形成

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Mortality in Pts Treated With Extended Duration Dual Antiplatelet Therapy (DAPT) After DES

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Poor Responders to Statins at Risk for CAD Progression

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Un Estudio del Mundo Real Avala el Uso de Fondaparinux sobre Heparina en el Manejo de los cuadros de NSTEMI

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Long-term Ticagrelor Therapy Cost-Effective in US Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content